Kinnevik Results Presentation Deck

WE DEPLOYED SEK 1.9BN IN FOLLOW-ONS IN Q2 EXECUTING ON OUR MAIN 2023 PRIORITY TO INCREASE THE IMPACT OF OUR HIGH-CONVICTION BUSINESSES ■ Main strategic priority in 2023 is to use the market conditions to double-down in our high-conviction businesses by increasing our committed capital and accreting ownership In the quarter we deployed SEK 1.7bn into portfolio winners such as Spring Health, TravelPerk, Instabee, Recursion and HungryPanda Increasing Our Exposure To Portfolio Winners Supporting & Maximizing Impact of High-Conviction Businesses Spring Health is now our largest aggregate investment since the start of the current iteration of Kinnevik ■ ■ ■ In Q2, we invested an additional USD 100m on top of the 50m invested in Q1 this year, accreting ownership from 5 to 12% The company grew revenues by 270% in 2022, and is fully funded to reach cash flow profitability We also deployed meaningful capital into TravelPerk and Instabee, businesses from our early 2018 vintage TravelPerk breached USD 100m in run-rate revenues last year Instabee is currently focusing on merger integration and unleashing EBITDA profitability, and is growing revenues across its entire footprint by gaining market share in a contracting e-commerce market Spring Health Q3 '21 Q4 '18 b Q2 '18 Repeated Investment Through the Journey Invested Capital, Fair Value & Growth TravelPerk Q2 '23 Q2 '23 Q2 '23 Our permanent capital structure and ability to multiply our investment in companies as they grow and prove their business is one of our key competitive advantages as an investor 3.3bn Fair Value 2.5bn Invested 5x NTM Growth Since 1st Investment 2.3bn Fair Value 0.9bn Invested 31x 1.7bn 0.7bn 32x NTM Growth Since 1st Investment Fair Value Invested NTM Growth Since 1st Investment KINNEVIK

View entire presentation